Eddie Reed

Biochemistry, Genetics and Molecular Biology · Life Sciences

48h-index8.1kcitations189works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA Repair Mechanisms(34), Cancer Treatment and Pharmacology(22), Prostate Cancer Treatment and Research(16), Metal complexes synthesis and properties(14), Cancer-related Molecular Pathways(14)

Publications189 total

Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells
UNC Libraries·2021Open Access
DNA Adducts of Cisplatin in Nucleated Peripheral Blood Cells and Tissues of Cancer Patients
Progress in tumor research·2015· 19 cited
ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
PLoS ONE·2014· 169 citedOpen Access
Gli1 contributes to cellular resistance to cisplatin through altered cellular accumulation of the drug
Oncology Reports·2014· 24 citedOpen Access
Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer
PLoS ONE·2014· 76 citedOpen Access
Validation of a venous thromboembolism risk assessment model in gynecologic oncology
Gynecologic Oncology·2014· 107 cited
GLI1 upregulates C-JUN through a specific 130-kDa isoform
International Journal of Oncology·2013· 11 citedOpen Access
DNA Repair: ERCC1, Nucleotide Excision Repair, and Platinum Resistance
Cancer drug discovery and develogment/Cancer drug discovery and development·2013· 5 cited
β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK
International Journal of Oncology·2013· 71 citedOpen Access
Reversal of the Warburg effect in breast cancer cells by a novel agent.
Journal of Clinical Oncology·2013
Translational Nucleotide Excision Repair in Triple Negative Breast Cancer
The FASEB Journal·2013
Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer.
Cancer Research·2013· 1 cited
β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas.
PubMed·2013· 39 citedOpen Access
Abstract LB-223: A specific Isoform of Gli1 binds the promoter region of c-fos in A2780-CP70 human ovarian cancer cells.
Cancer Research·2013
Duration of Cisplatin Excretion in Breast Milk
Journal of Human Lactation·2013· 12 citedOpen Access
β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells.
PubMed·2013· 25 cited
Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs
Medical Oncology·2013· 41 cited
Pharmacodynamic stimulation of thrombogenesis by angiotensin (1–7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy
Cancer Chemotherapy and Pharmacology·2013· 27 cited
Are race-specific ERCC1 haplotypes in melanoma cases versus controls related to the predictive and prognostic value of ERCC1 N118N?
BMJ Open·2013· 10 citedOpen Access
Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells
Medical Oncology·2012· 59 cited
page 1 of 10Next →

Frequent Co-authors

William D. Figg(10), Gangduo Wang(6), Qingdi Li(6), William L. Dahut(4), Oliver Sartor(4), Nancy A. Dawson(3), Charles E. Myers(3), Michael A. Finan(3), Rodney P. Rocconi(3), Seth M. Steinberg(3), James M. Pluda(3), Xiping Li(3), Jinshun Zhao(3), Raymond C. Bergan(3), Richard M. Lush(3), David Venzon(3), Benjamín C. Bostick(3), Jing Yu(3), Kang Bo Lee(3), Qingdi Quentin Li(3)